The Effect of Small Doses of Stable Iodine in Patients with Hyperthyroidism
1962; American College of Physicians; Volume: 56; Issue: 4 Linguagem: Inglês
10.7326/0003-4819-56-4-577
ISSN1539-3704
Autores Tópico(s)History of Medicine Studies
ResumoArticle1 April 1962The Effect of Small Doses of Stable Iodine in Patients with HyperthyroidismROBERT VOLPÉ, M.D., F.R.C.P.(C), MACALLISTER W. JOHNSTON, M.D., F.R.C.P.(C)ROBERT VOLPÉ, M.D., F.R.C.P.(C), MACALLISTER W. JOHNSTON, M.D., F.R.C.P.(C)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-56-4-577 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe administration of stable iodine to hyperthyroid patients has long been known to produce at least temporary clinical benefit. Iodine was used in the treatment of toxic goiter as early as 1840 by von Basedow (1) and in 1854 by Stokes (2). Although Trousseau (3) disagreed with the earlier enthusiasm, in 1868 he convincingly described the beneficial effect of iodine in hyperthyroidism after he had accidentally prescribed tincture of iodine instead of tincture of digitalis to a hyperthyroid patient. In spite of his success with this case, he continued to look upon iodine as a dangerous drug for this disease....References1. VON BASEDOW CA: Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhoehle. Wschr. Ges. Heilk. 6: 197, 1840. Google Scholar2. STOKES W: Diseases of the Heart and Aorta, Hodges and Smith, Dublin, 1854, p. 278. Google Scholar3. TROUSSEAU A: Lectures on Clinical Medicine, vol. 1, lecture XIX, Exophthalmic goitre of Graves' disease, New Sydenham Society, London, 1868, p. 587. Google Scholar4. CHEADLE WB: Exophthalmic goitre. Report of cases treated with iodine. St. George's Hosp. Rep. 4: 175, 1869. Google Scholar5. CHEADLE WB: Exophthalmic goitre. Report of six cases treated with iodine. St. George's Hosp. Rep. 7: 81, 1875. Google Scholar6. MARINELENHART DC: The pathological anatomy of the human thyroid gland. Arch. Intern. Med. 7: 506, 1911. CrossrefGoogle Scholar7. NEISSER E: Ueber Jodbehandlung bei Thyreotoxikose. Berlin Klin. Wschr. 57: 461, 1920. Google Scholar8. LOEWYZONDEK AH: Morbus Basedowii und Jodtherapie, Klinische und gasanalytische Beobachtungen. Deutsch. Med. Wschr. 47: 1387, 1921. CrossrefGoogle Scholar9. PLUMMER HS: Results of administering iodine to patients having exophthalmic goiter. J. A. M. A. 80: 1955, 1923. Google Scholar10. PLUMMERBOOTHBY HSWM: The value of iodine in exophthalmic goiter. J. Iowa Med. Soc. 14: 66, 1924. Google Scholar11. JAGICSPENGLER NG: Weitere Beobachtungen über Jodwirkung bei Strumen. Wien. Klin. Wschr. 37: 116, 1924. Google Scholar12. COWELLMELLANBY SJE: The effect of iodine on hyperthyroidism in man. Quart. J. Med. 18: 1, 1924-5. CrossrefGoogle Scholar13. CATTELL RB: The elimination of the iodine in the urine in normal persons and in exophthalmic goitre. Boston Med. Surg. J. 195: 69, 1926. CrossrefGoogle Scholar14. WAHLBERG J: Das Thyreotoxikosesyndrom und seine Reaktion bei kleinen Joddosen. Marcatois Trycheri Aktiebolag, Helsingfors, Mercator, 1926. Google Scholar15. CAMPBELL WR: Personal communication. Google Scholar16. THOMPSONBRAILEYTHOMPSON WOAGPK: The effective range of iodine dosage in exophthalmic goiter. J. A. M. A. 91: 1719, 1928. CrossrefGoogle Scholar17. THOMPSONBRAILEYTHOMPSONTHORP WOAGPKEG: The range of effective iodine dosage in exophthalmic goiter. I. The effect on basal metabolism of rest and of the daily administration of one drop of compound solution of iodine. Arch. Intern. Med. 45: 261, 1930. CrossrefGoogle Scholar18. THOMPSONTHORPTHOMPSONCOHEN WOEGPKAC: The range of effective iodine dosage in exophthalmic goiter. II. The effect on basal metabolism of the daily administration of one-half drop of compound solution of iodine. Arch. Intern. Med. 45: 420, 1930. CrossrefGoogle Scholar19. THOMPSONCOHENTHOMPSONTHORPBRAILEY WOACPKEGAG: The range of effective iodine dosage in exophthalmic goiter. III. The effect of basal metabolism of the daily administration of one-quarter drop of compound solution of iodine and of slightly smaller doses, with a summary of results to date. Arch. Intern. Med. 45: 430, 1930. CrossrefGoogle Scholar20. THOMPSONTHOMPSONBRAILEYCOHEN WOPKAGAC: Prolonged treatment of exophthalmic goiter by iodine alone. Arch. Intern. Med. 45: 481, 1930. CrossrefGoogle Scholar21. THOMPSONTAYLORTHOMPSONDICKIE WOSGPKLF: Quantitative observations on the effect of iodine in exophthalmic goiter in Chicago. Western J. Surg. 43: 489, 1935. Google Scholar22. STARRSEGALLMEANS PHNJH: The effect of iodine in exophthalmic goiter. Arch. Intern. Med. 34: 355, 1924. CrossrefGoogle Scholar23. GREERDE GROOT MALJ: The effect of stable iodine on thyroid secretion in man. Metabolism 5: 682, 1956. MedlineGoogle Scholar24. SOLOMON DH: Factors affecting the fractional rate of release of radioiodine from the thyroid gland in man. Metabolism 5: 667, 1956. MedlineGoogle Scholar25. GOLDSMITHEISELE REML: The effect of iodide on the release of thyroid hormone in hyperthyroidism. J. Clin. Endocr. 15: 864, 1955. Google Scholar26. GOLDSMITHHERBERTRUTSCH RECG: The effect of iodine on the release of thyroid hormone in hyperthyroidism; further observations. J. Clin. Endocr. 18: 367, 1958. CrossrefGoogle Scholar27. MERCERSHARARDWESTERINKADAMS CJAGJDD: Slowing of thyroid secretion by iodide in euthyroid people. Lancet 2: 19, 1960. CrossrefGoogle Scholar28. ANSELLMILLER GH: Influence of iodine on the release of thyroid hormone in thyrotoxicosis, Lancet 2: 5, 1952. CrossrefMedlineGoogle Scholar29. BENUALIPSETT RSMB: Effect of iodide on the action of TSH in the hypophysectomized patient. J. Clin. Endocr. 19: 19, 1959. CrossrefGoogle Scholar30. FRIEND DG: Iodine therapy and the importance of quantitating the dose. New Engl. J. Med. 263: 1358, 1960. CrossrefMedlineGoogle Scholar31. DANOWSKIMATEERWEIGANDPETERSGREENMAN TSFFAJHJH: Serum iodine fractions in subjects receiving potassium iodide in small dosage. J. Clin. Endocr. 10: 532, 1950. CrossrefGoogle Scholar32. BROWNPAGE HBIH: Effect of oral iodide in serum butanol-insoluble protein-bound iodine in various species. Circulation 10: 714, 1954. CrossrefMedlineGoogle Scholar33. BARKERHUMPHREYSOLEY SBMJMH: The clinical determination of protein-bound iodine. J. Clin. Invest. 30: 55, 1951. CrossrefMedlineGoogle Scholar34. HUBER N: The difficulties encountered in the measurement of the serum protein-bound iodine and the value of this test in the assessment of thyroid function. Canad. J. Med. Techn. 18: 77, 1956. MedlineGoogle Scholar35. PALEYSOBELYALOW KRESRS: Some aspects of thyroidal iodine metabolism in a case of iodine induced hypothyroidism. J. Clin. Endocr. 18: 79, 1958. CrossrefGoogle Scholar36. OPPENHEIMERMCPHERSON JHHP: The syndrome of iodide induced goiter and myxoedema. Amer. J. Med. 30: 281, 1961. CrossrefMedlineGoogle Scholar37. WOLFFCHAIKOFF JIL: Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem. 174: 555, 1948. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Toronto,From the Department of Medicine, University of Toronto, The Medical Service, Toronto General Hospital, and the Clinical Investigation Unit, Sunnybrook (D.V.A.) Hospital, Toronto, Canada.Presented at the annual meeting of the Royal College of Physicians and Surgeons of Canada, Toronto, Ontario, Canada, January 18-20, 1962.Supported by grants from the National Research Council of Canada.Requests for reprints should be addressed to Robert Volpé, M.D., Department of Medicine, University of Toronto, Toronto, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByClinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease PatientsTaking all the sideroads of hyperthyroidism therapy: Pitfalls and possibilitiesClinical experience of treating Graves' hyperthyroidism complicated with malignancy—The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropeniaRelationship Between the Effectiveness of Inorganic Iodine and the Severity of Graves Thyrotoxicosis: A Retrospective StudyComparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe HyperthyroidismThe effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacementThyroid Iodine Content Measurement Helps for the Diagnosis of Hyper-Hyroidism with Undetectable Radioiodine UptakeIs There a Place for Long-Term Stable Iodine in the Treatment of Graves' Disease?In vivo vital staining as an aid to identification of esophagogastric mucosal junction in manKombinierte parenterale Therapie mit Thiamazol und Jodid bei schwerer HyperthyreoseIodide goiter and the pharmacologic effects of excess iodide 1 April 1962Volume 56, Issue 4Page: 577-589KeywordsCancer treatmentChartsDrugsHospital medicineHyperthyroidismMedical servicesProteinsSurgeonsThyroidThyroid-stimulating hormone Issue Published: 1 April 1962 PDF DownloadLoading ...
Referência(s)